Purpose
To identify the molecules responsible for amyloid β-peptide (1–40) (Aβ(1–40)) uptake by the liver, which play a major role in the systemic clearance of Aβ(1–40).
Methods
The liver uptake index method was used to examine the mechanisms of Aβ(1–40) uptake by the liver in vivo.
Results
[125I]Aβ(1–40) uptake by the rat liver was concentration-dependent (50% saturation concentration = 302 nM). The inhibitory spectrum of Aβ fragments indicated that 17–24 in Aβ (LVFFAEDV) was the putative sequence responsible for hepatic Aβ(1–40) uptake. Receptor-associated protein (RAP) inhibited [125I]Aβ(1–40) uptake by 48%. RAP-deficient mice, in which low-density lipoprotein receptor-related protein 1 (LRP-1) expression was suppressed, showed a 46% reduction in [125I]Aβ(1–40) uptake by the liver. siRNA-mediated suppression of LRP-1 expression in the liver resulted in a reduction in [125I]Aβ(1–40) uptake by 64%. Both the expression of LRP-1 in the liver and the hepatic Aβ(1–40) uptake were significantly reduced in 13-month-old rats compared with 7-week-old rats.
Conclusions
LRP-1 is the major receptor responsible for the saturable uptake of plasma free Aβ(1–40) by the liver. Reduction of LRP-1 expression will play a role in the age-related reduction in hepatic Aβ(1–40) clearance.
Similar content being viewed by others
Abbreviations
- Aβ:
-
amyloid β-peptide
- AD:
-
Alzheimer's disease
- AGEs:
-
advanced glycation end products
- apoE:
-
apolipoprotein E
- BBB:
-
blood–brain barrier
- BSA:
-
bovine serum albumin
- CAA:
-
cerebrovascular amyloid angiopathy
- FITC:
-
fluorescein-4-isothiocyanate
- LDL:
-
low-density lipoprotein
- LRP-1:
-
LDL receptor-related protein 1
- LUI:
-
liver uptake index
- RAGE:
-
receptor for AGEs
- RAP:
-
receptor-associated protein
- SDS:
-
sodium dodecylsulfate
- siRNA:
-
short interfering RNA
- SR-A:
-
scavenger receptor type A
References
E. M. Castano F. Prelli C. Soto R. Beavis E. Matsubara M. Shoji B. Frangione (1996) ArticleTitleThe length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1–42 in Alzheimer's disease J. Biol. Chem. 271 32185–32191 Occurrence Handle8943274 Occurrence Handle1:CAS:528:DyaK2sXit1Sguw%3D%3D Occurrence Handle10.1074/jbc.271.50.32185
M. Citron T. S. Diehl G. Gordon A. L. Biere P. Seubert D. J. Selkoe (1996) ArticleTitleEvidence that the 42- and 40-amino acid forms of amyloid beta protein are generated from the beta-amyloid precursor protein by different protease activities Proc. Natl. Acad. Sci. USA 93 13170–13175 Occurrence Handle8917563 Occurrence Handle1:CAS:528:DyaK28XmvV2qt70%3D Occurrence Handle10.1073/pnas.93.23.13170
P. Seubert C. Vigo-Pelfrey F. Esch M. Lee H. Dovey D. Davis S. Sinha M. Schlossmacher J. Whaley C. Swindlehurst R. Mccormack R. Wolfert D. J. Selkou I. Lieberburg D. Schenk (1992) ArticleTitleIsolation and quantification of soluble Alzheimer's beta-peptide from biological fluids Nature 359 325–327 Occurrence Handle1406936 Occurrence Handle1:CAS:528:DyaK38XmtFSisrc%3D Occurrence Handle10.1038/359325a0
A. L. Biere B. Ostaszewski E. R. Stimson B. T. Hyman J. E. Maggio D. J. Selkoe (1996) ArticleTitleAmyloid beta-peptide is transported on lipoproteins and albumin in human plasma J. Biol. Chem. 271 32916–32922 Occurrence Handle8955133 Occurrence Handle1:CAS:528:DyaK2sXnt1Sq Occurrence Handle10.1074/jbc.271.51.32916
J. F. Poduslo G. L. Curran J. J. Haggard A. L. Biere D. J. Selkoe (1997) ArticleTitlePermeability and residual plasma volume of human, Dutch variant, and rat amyloid beta-protein 1-40 at the blood–brain barrier Neurobiol. Dis. 4 27–34 Occurrence Handle9258909 Occurrence Handle1:CAS:528:DyaK2sXls1Wkt7w%3D Occurrence Handle10.1006/nbdi.1997.0132
E. Hone I. J. Martins J. Fonte R. N. Martins (2003) ArticleTitleApolipoprotein E influences amyloid-beta clearance from the murine periphery J. Alzheimer's Dis. 5 1–8 Occurrence Handle1:CAS:528:DC%2BD3sXns1Cqtg%3D%3D
J. Ghiso M. Shayo M. Calero D. Ng Y. Tomidokoro S. Gandy A. Rostagno B. Frangione (2004) ArticleTitleSystemic catabolism of Alzheimer's Abeta 40 and Abeta 42 J. Biol. Chem. 279 45897–45908 Occurrence Handle15322125 Occurrence Handle1:CAS:528:DC%2BD2cXovVCntrk%3D Occurrence Handle10.1074/jbc.M407668200
K. K. Kandimalla G. L. Curran S. S. Holasek E. J. Gilles T. M. Wengenack J. F. Poduslo (2005) ArticleTitlePharmacokinetic analysis of the blood–brain barrier transport of 125I-amyloid beta protein 40 in wild-type and Alzheimer's disease transgenic mice (APP, PS1) and its implications for amyloid plaque formation J. Pharmacol. Exp. Ther. 313 1370–1378 Occurrence Handle15743932 Occurrence Handle1:CAS:528:DC%2BD2MXkslekurc%3D Occurrence Handle10.1124/jpet.104.081901
J. B. Mackic M. H. Weiss W. Miao E. Kirkman J. Ghiso M. Calero J. Bading B. Frangione B. V. Zlokovic (1998) ArticleTitleCerebrovascular accumulation and increased blood–brain barrier permeability to circulating Alzheimer's amyloid beta peptide in aged squirrel monkey with cerebral amyloid angiopathy J. Neurochem. 70 210–215 Occurrence Handle9422364 Occurrence Handle1:CAS:528:DyaK1cXmt1Sl Occurrence Handle10.1046/j.1471-4159.1998.70010210.x
J. B. Mackic J. Bading J. Ghiso L. Walker T. Wisniewski B. Frangione B. V. Zlokovic (2002) ArticleTitleCirculating amyloid-beta peptide crosses the blood–brain barrier in aged monkeys and contributes to Alzheimer's disease lesions Vascul. Pharmacol. 38 303–313 Occurrence Handle12529925 Occurrence Handle1:CAS:528:DC%2BD38XosF2kt74%3D Occurrence Handle10.1016/S1537-1891(02)00198-2
C. C. Smith D. J. Betteridge (2004) ArticleTitlePlasma beta-amyloid (A beta) 40 concentration, lipid status and age in humans Neurosci. Lett. 367 48–50 Occurrence Handle15308295 Occurrence Handle1:CAS:528:DC%2BD2cXmslelu70%3D Occurrence Handle10.1016/j.neulet.2004.05.081
W. J. Strittmatter K. H. Weisgraber D. Y. Huang L. M. Dong G. S. Salvesen M. Pericak-Vance D. Schmechel A. M. Saunders D. Goldgaber A. D. Roses (1993) ArticleTitleBinding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease Proc. Natl. Acad. Sci. USA 90 8098–8102 Occurrence Handle8367470 Occurrence Handle1:CAS:528:DyaK3sXlslyksrY%3D Occurrence Handle10.1073/pnas.90.17.8098
J. Herz D. K. Strickland (2001) ArticleTitleLRP: a multifunctional scavenger and signaling receptor J. Clin. Invest. 108 779–784 Occurrence Handle11560943 Occurrence Handle1:CAS:528:DC%2BD3MXmvV2nt7c%3D Occurrence Handle10.1172/JCI200113992
M. Shibata S. Yamada S. R. Kumar M. Calero J. Bading B. Frangione D. M. Holtzman C. A. Miller D. K. Strickland J. Ghiso B. V. Zlokovic (2000) ArticleTitleClearance of Alzheimer's amyloid-beta(1–40) peptide from brain by LDL receptor-related protein-1 at the blood–brain barrier J. Clin. Invest. 106 1489–1499 Occurrence Handle11120756 Occurrence Handle1:CAS:528:DC%2BD3cXovFagtbs%3D
R. Deane Z. Wu A. Sagare J. Davis S. Du Yan K. Hamm F. Xu M. Parisi B. LaRue H. W. Hu P. Spijkers H. Guo X. Song P. J. Lenting W. E. Nostrand ParticleVan B. V. Zlokovic (2004) ArticleTitleLRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms Neuron 43 333–344 Occurrence Handle15294142 Occurrence Handle1:CAS:528:DC%2BD2cXmvFOisLY%3D Occurrence Handle10.1016/j.neuron.2004.07.017
S. K. Moestrup J. Gliemann G. Pallesen (1992) ArticleTitleDistribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues Cell Tissue Res. 269 375–382 Occurrence Handle1423505 Occurrence Handle1:CAS:528:DyaK38XmtV2nt74%3D Occurrence Handle10.1007/BF00353892
W. M. Pardridge L. J. Mietus (1979) ArticleTitleTransport of protein-bound steroid hormones into liver in vivo Am. J. Physiol. 237 E367–E372 Occurrence Handle495715 Occurrence Handle1:CAS:528:DyaE1MXls1yrt7g%3D
J. V. Valencia S. C. Weldon D. Quinn G. H. Kiers J. DeGroot J. M. TeKoppele T. E. Hughes (2004) ArticleTitleAdvanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics Anal. Biochem. 324 68–78 Occurrence Handle14654047 Occurrence Handle1:CAS:528:DC%2BD3sXptl2qt74%3D Occurrence Handle10.1016/j.ab.2003.09.013
E. M. Cornford L. D. Braun W. M. Pardridge W. H. Oldendorf (1980) ArticleTitleBlood flow rate and cellular influx of glucose and arginine in mouse liver in vivo Am. J. Physiol. 238 H553–H560 Occurrence Handle7377328 Occurrence Handle1:CAS:528:DyaL3cXhslyjtr4%3D
W. M. Pardridge L. J. Mietus (1982) ArticleTitleKinetics of neutral amino acid transport through the blood–brain barrier of the newborn rabbit J. Neurochem. 38 955–962 Occurrence Handle7062043 Occurrence Handle1:CAS:528:DyaL38XkslSjsb8%3D
K. Yamaoka Y. Tanigawara T. Nakagawa T. Uno (1981) ArticleTitleA pharmacokinetic analysis program (multi) for microcomputer J. Pharmacobio-dyn. 4 879–885 Occurrence Handle7328489 Occurrence Handle1:CAS:528:DyaL38XksFyntg%3D%3D
P. O. Seglen (1976) ArticleTitlePreparation of isolated rat liver cells Methods Cell Biol. 13 29–83 Occurrence Handle177845 Occurrence Handle1:CAS:528:DyaE28XkslCgtbY%3D
F. Liu Y. Song D. Liu (1999) ArticleTitleHydrodynamics-based transfection in animals by systemic administration of plasmid DNA Gene Ther. 6 1258–1266 Occurrence Handle10455434 Occurrence Handle1:CAS:528:DyaK1MXksVKht74%3D Occurrence Handle10.1038/sj.gt.3300947
K. Wakayama S. Ohtsuki H. Takanaga K. Hosoya T. Terasaki (2002) ArticleTitleLocalization of norepinephrine and serotonin transporter in mouse brain capillary endothelial cells Neurosci. Res. 44 173–180 Occurrence Handle12354632 Occurrence Handle1:CAS:528:DC%2BD38Xnt1KlsLo%3D Occurrence Handle10.1016/S0168-0102(02)00120-7
M. C. Irizarry (2004) ArticleTitleBiomarkers of Alzheimer disease in plasma NeuroRx 1 226–234 Occurrence Handle15717023 Occurrence Handle10.1602/neurorx.1.2.226
D. M. Ward J. Kaplan (1990) ArticleTitleThe rate of internalization of different receptor–ligand complexes in alveolar macrophages is receptor-specific Biochem. J. 270 369–374 Occurrence Handle1698058 Occurrence Handle1:CAS:528:DyaK3cXlsFSlt70%3D
D. M. Ward R. Ajioka J. Kaplan (1989) ArticleTitleCohort movement of different ligands and receptors in the intracellular endocytic pathway of alveolar macrophages J. Biol. Chem. 264 8164–8170 Occurrence Handle2470742 Occurrence Handle1:CAS:528:DyaL1MXktVCrs7c%3D
T. Pillot M. Goethals B. Vanloo C. Talussot R. Brasseur J. Vandekerckhove M. Rosseneu L. Lins (1996) ArticleTitleFusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide J. Biol. Chem. 271 28757–28765 Occurrence Handle8910517 Occurrence Handle1:CAS:528:DyaK28XntFKntLc%3D Occurrence Handle10.1074/jbc.271.46.28757
J. T. Jarrett E. P. Berger P. T. Lansbury SuffixJr. (1993) ArticleTitleThe carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease Biochemistry 32 4693–4697 Occurrence Handle8490014 Occurrence Handle1:CAS:528:DyaK3sXksVKktL0%3D Occurrence Handle10.1021/bi00069a001
G. Joslin J. E. Krause A. D. Hershey S. P. Adams R. J. Fallon D. H. Perlmutter (1991) ArticleTitleAmyloid-beta peptide, substance P, and bombesin bind to the serpin–enzyme complex receptor J. Biol. Chem. 266 21897–21902 Occurrence Handle1718986 Occurrence Handle1:CAS:528:DyaK3MXlvF2lsbg%3D
M. L. Matter Z. Zhang C. Nordstedt E. Ruoslahti (1998) ArticleTitleThe alpha5beta1 integrin mediates elimination of amyloid-beta peptide and protects against apoptosis J. Cell Biol. 141 1019–1030 Occurrence Handle9585419 Occurrence Handle1:CAS:528:DyaK1cXjt1Kmsro%3D Occurrence Handle10.1083/jcb.141.4.1019
L. Xie E. Helmerhorst K. Taddei B. Plewright W. Bronswijk ParticleVan R. Martins (2002) ArticleTitleAlzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor J. Neurosci. 22 RC221 Occurrence Handle12006603
J. B. Mackic M. Stins J. G. McComb M. Calero J. Ghiso K. S. Kim S. D. Yan D. Stern A. M. Schmidt B. Frangione B. V. Zlokovic (1998) ArticleTitleHuman blood–brain barrier receptors for Alzheimer's amyloid-beta 1–40. Asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer J. Clin. Invest. 102 734–743 Occurrence Handle9710442 Occurrence Handle1:CAS:528:DyaK1cXlsFaru7o%3D
R. Deane S. Du Yan R. K. Submamaryan B. LaRue S. Jovanovic E. Hogg D. Welch L. Manness C. Lin J. Yu H. Zhu J. Ghiso B. Frangione A. Stern A. M. Schmidt D. L. Armstrong B. Arnold B. Liliensiek P. Nawroth F. Hofman M. Kindy D. Stern B. Zlokovic (2003) ArticleTitleRAGE mediates amyloid-beta peptide transport across the blood–brain barrier and accumulation in brain Nat. Med. 9 907–913 Occurrence Handle12808450 Occurrence Handle1:CAS:528:DC%2BD3sXkvFOjsL0%3D Occurrence Handle10.1038/nm890
D. E. Kang C. U. Pietrzik L. Baum N. Chevallier D. E. Merriam M. Z. Kounnas S. L. Wagner J. C. Troncoso C. H. Kawas R. Katzman E. H. Koo (2000) ArticleTitleModulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway J. Clin. Invest. 106 1159–1166 Occurrence Handle11067868 Occurrence Handle1:CAS:528:DC%2BD3cXnvFyqur0%3D
G. Bu (2001) ArticleTitleThe roles of receptor-associated protein (RAP) as a molecular chaperone for members of the LDL receptor family Int. Rev. Cytol. 209 79–116 Occurrence Handle11580203 Occurrence Handle1:CAS:528:DC%2BD38XhvVelurs%3D Occurrence Handle10.1016/S0074-7696(01)09011-8
J. Herz D. E. Clouthier R. E. Hammer (1992) ArticleTitleLDL receptor-related protein internalizes and degrades uPA–PAI-1 complexes and is essential for embryo implantation Cell 71 411–421 Occurrence Handle1423604 Occurrence Handle1:CAS:528:DyaK3sXksVKr Occurrence Handle10.1016/0092-8674(92)90511-A
T. E. Willnow S. A. Armstrong R. E. Hammer J. Herz (1995) ArticleTitleFunctional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo Proc. Natl. Acad. Sci. USA 92 4537–4541 Occurrence Handle7538675 Occurrence Handle1:CAS:528:DyaK2MXls1aksb8%3D Occurrence Handle10.1073/pnas.92.10.4537
T. E. Willnow A. Rohlmann J. Horton H. Otani J. R. Braun R. E. Hammer J. Herz (1996) ArticleTitleRAP, a specialized chaperone, prevents ligand-induced ER retention and degradation of LDL receptor-related endocytic receptors EMBO J. 15 2632–2639 Occurrence Handle8654360 Occurrence Handle1:CAS:528:DyaK28XjvVWitL4%3D
A. Rohlmann M. Gotthardt R. E. Hammer J. Herz (1998) ArticleTitleInducible inactivation of hepatic LRP gene by Cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants J. Clin. Invest. 101 689–695 Occurrence Handle9449704 Occurrence Handle1:CAS:528:DyaK1cXosVamsA%3D%3D Occurrence Handle10.1172/JCI1240
W. M. Pardridge E. M. Landaw L. P. Miller L. D. Braun W. H. Oldendorf (1985) ArticleTitleCarotid artery injection technique: bounds for bolus mixing by plasma and by brain J. Cereb. Blood Flow Metab. 5 576–583 Occurrence Handle4055927 Occurrence Handle1:CAS:528:DyaL28XkvVajtA%3D%3D
D. Schenk (2002) ArticleTitleAmyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning Nat. Rev. Neurosci. 3 824– 828 Occurrence Handle12360327 Occurrence Handle1:CAS:528:DC%2BD38XnsVGqur8%3D Occurrence Handle10.1038/nrn938
R. B. DeMattos K. R. Bales D. J. Cummins J. C. Dodart S. M. Paul D. M. Holtzman (2001) ArticleTitlePeripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. USA 98 8850–8885 Occurrence Handle11438712 Occurrence Handle1:CAS:528:DC%2BD3MXls1Wiurk%3D Occurrence Handle10.1073/pnas.151261398
D. M. Wilcock A. Rojiani A. Rosenthal S. Subbarao M. J. Freeman M. N. Gordon D. Morgan (2004) ArticleTitlePassive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage J. Neuroinflammation 1 24 Occurrence Handle15588287 Occurrence Handle10.1186/1742-2094-1-24 Occurrence Handle1:CAS:528:DC%2BD2MXjs1elsLk%3D
Acknowledgments
We would like to thank Dr. T. Yokota for valuable discussions, and Ms. N. Funayama for secretarial assistance. This study was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas 17025005 from The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and a 21st Century Center of Excellence (COE) Program grant from the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tamaki, C., Ohtsuki, S., Iwatsubo, T. et al. Major Involvement of Low-Density Lipoprotein Receptor-Related Protein 1 in the Clearance of Plasma Free Amyloid β-Peptide by the Liver. Pharm Res 23, 1407–1416 (2006). https://doi.org/10.1007/s11095-006-0208-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-0208-7